VEGFA and head and neck squamous cell carcinoma: For example, Pore et al. [38] demonstrated that gefitinib and erlotinib decreased VEGF mRNA expression and decreased the secretion of VEGF protein in response to hypoxia in SQ20B HNSCC cells.